BioMed Research International · Nov 15, 2026

Elevated Phosphorylated Tau and Amyloid‐Beta 42 in Sleep Apnoea: Evidence From a Systematic Review and Meta‐Analysis

By Parsons S, Williamson S, Corrêa SAL

Background: Alzheimer′s disease (AD) biomarkers were detected in the cerebrospinal fluid, plasma and brain of obstructive sleep apnoea hypopnoea syndrome (OSAHS) sufferers. The mechanism mediating these changes remains disputed. This study aims to investigate the relationship between chronic intermittent hypoxia caused by OSAHS and AD blood biomarker levels, allowing a better understanding and consideration of the systemic impact of OSAHS on AD development. Methods: We searched PubMed, Scopus and Web of Science databases and conducted the research according the PRISMA 2020 guidelines. Studies were included if they reported hypoxic parameters in an OASHS group and a control group and analyses of blood biomarker levels including amyloid‐beta and tau. The Newcastle–Ottawa Scale was used to assess study quality. Results: Eight studies including 435 OSAHS patients and 281 controls were assessed. Pooled analysis showed elevated A β ₄₂ (SMD = 0.27, 95 % (CI) = 0.03 to 0.51, I ² = 56 % , p = 0.03), T‐tau (SMD = 0.60, 95 % (CI) = 0.26 to 0.94, I ² = 63 % , p = 0.0006) and p‐tau181 (SMD = 0.41, 95 % (CI) = 0.03 to 0.80, effect size = 2.12, I ² = 51 % , p = 0.03) in the OSAHS group compared with controls, though no difference in A β ₄₀ (SMD = 0.33, 95 % (CI) = −0.27 to 0.94, effect size = 1.09, I ² = 77 % , p = 0.28) levels was observed. Reduced mean oxygen saturation is associated with elevated T‐tau (SMD = −0.36, 95 % (CI) = −0.62 to − 0.10, I ² = 0 % , p = 0.007) and p‐tau181 (SMD = −0.61, 95 % (CI) = −0.96 to − 0.27, I ² = 0 % , p = 0.0004) but not with A β ₄₂ (SMD = −0.19, 95 % (CI) = −0.70 to 0.32, I ² = 76 % , p = 0.46). Elevated oxygen desaturation index was associated with increased A β ₄₂ (SMD = −0.37, 95 % (CI) = −0.56 to − 0.18, I ² = 49 % , p = 0.0001) and T‐tau (SMD = −0.54, 95 % (CI) = −0.90 to − 0.17, I ² = 58 % , p = 0.004). Conclusions: Findings show that chronic intermittent hypoxia is associated with increased blood A β ₄₂ levels, , but not A β ₄₀ , in the OSAHS group. This may suggest that hypoxia contributes to processes regulating the production and degradation of neurotoxic amyloid‐beta peptides. Further experimental investigation is required to determine whether treating OSAHS and restoring optimal oxygen saturation conditions in the brain affects blood A β ₄₂ levels and whether OSAHS is a modifiable disorder that may increase the risk of developing AD.

doi.org/10.1155/bmri/4366369Open accessPubMed 43034879Mechanisms

AgingResearch.News